NeuroVive Pharmaceutical AB Beta
¿Qué es el Beta de NeuroVive Pharmaceutical AB?
El Beta de NeuroVive Pharmaceutical AB es 0.93
¿Cuál es la definición de Beta?
BETA indica si una acción es más o menos volátil que el mercado en su conjunto. Una beta inferior a 1 indica que el stock es menos volátil que el mercado, mientras que una beta más de 1 indica que el stock es más volátil. La volatilidad se mide como la fluctuación del precio alrededor de la media.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta de compañías en Sector Miscellaneous en LSE en comparadas con NeuroVive Pharmaceutical AB
¿Qué hace NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Empresas con beta similar a NeuroVive Pharmaceutical AB
- Megasoft tiene Beta de 0.93
- Manitex International Inc tiene Beta de 0.93
- Premier Gold Mines tiene Beta de 0.93
- Premier Gold Mines tiene Beta de 0.93
- Premier Gold Mines tiene Beta de 0.93
- BAIC Motor tiene Beta de 0.93
- NeuroVive Pharmaceutical AB tiene Beta de 0.93
- iCar Asia tiene Beta de 0.93
- Wesbanco tiene Beta de 0.93
- Sumitomo Mitsui Inc tiene Beta de 0.93
- Midnight Sun Mining tiene Beta de 0.93
- Bio-Rad Laboratories tiene Beta de 0.93
- Foncière Euris SA tiene Beta de 0.93